PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

Affordable two-chip Beacon Select system to broaden customer access to innovative high throughput, function-first antibody discovery capabilities.

Related Keywords

Hynes Convention Center ,Massachusetts ,United States ,Boston ,Cdmos Cros ,Phenomex Inc ,Nasdaq ,Optob Discovery ,Beacon Select ,Antibody Discovery Workflow ,Protein Engineering ,Cell Therapy Summit ,Antibodies ,Ntibody ,Antibody Discovery ,Ntigen ,Bioprocessing ,Fell ,Cell Biology ,Chip ,Protein ,Eagents ,Research ,Technology ,